The miR-212 also suppresses the connective tissue growth factor (CTGF) (which promotes tumoral angiogenesis) and histone-H3 lysine-4 demethylase of RBP2 (which is upregulated in HCC) [20, 22, 23]. The gene discussed is CCN2; the disease is hepatocellular carcinoma.